1. Gibson, S. J. et al. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod. Cellular Immunology 218, 74–86 (2002).
2. Patel, U., Mark, N. M., Machler, B. C. & Levine, V. J. Imiquimod 5% cream induced psoriasis: a case report, summary of the literature and mechanism. Br J Dermatol 164 (2011).
3. OND, F. C. Application Type Application Number(s) Priority or Standard Submit Date(s) Received Date(s) PDUFA Goal Date Division/Office Reviewer Name(s) Review Completion Date Established Name (Proposed) Trade Name Therapeutic Class ™™ Formulation(s) Dosing Regimen Indication(s) Intended Population(s) NDA 505 (b)(1) 201153 Standard February 8, 2010 February 24, 2010 December 8, 2010 DDDP/OND Milena Lolic, M.D. October 6, 2010 Imiquimod Zyclara cream 3.75% Not determined Graceway Cream Daily for up to 8 weeks External genital warts and perianal warts 12 years and older. 1–72 (2011).
4. van der Fits, L. et al. Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice Is Mediated via the IL-23/IL-17 Axis. The Journal of Immunology 182, 5836–5845 (2009).
5. Cai, Y. et al. Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation. Immunity 35, 596–610 (2011).